AD1

NVIDIA DRIVE Powers Next Generation of Transportation — From Cars and Trucks to Robotaxis and Autonomous Delivery Vehicles

Retrieved on: 
Monday, March 18, 2024
EV, GTC, AD1, BYD, Brain, Nuro, Li Auto, EVS, XPENG, DRIVE, SAN, Nvidia Drive, WeRide, Transport, AI, LLM, NVIDIA, GAC, Nvidia Omniverse, Video game

DRIVE Thor is an in-vehicle computing platform architected for generative AI applications, which are becoming paramount within the automotive industry.

Key Points: 
  • DRIVE Thor is an in-vehicle computing platform architected for generative AI applications, which are becoming paramount within the automotive industry.
  • Hyper is currently using NVIDIA DRIVE Orin to power its flagship model Hyper GT, which features advanced level 2+ driving capabilities.
  • XPENG has also announced it will use the NVIDIA DRIVE Thor platform as the AI brain of its next-generation EV fleets.
  • The company plans to integrate DRIVE Thor in its Waabi Driver to power safe and reliable autonomous trucks at scale.

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation

Retrieved on: 
Wednesday, March 20, 2024
Biotechnology, Technology, Health, General Health, Pharmaceutical, Mental Health, Other Science, Other Technology, Research, Science, Clinical Trials, Agitation, AD1, Alzheimer's disease, Patient, CMAI, IGC, AAD, Caregiver burden, Dementia, Food, Pharmaceutical industry

IGC Pharma, Inc. (“IGC Pharma”, “IGC”, or the “Company”) (NYSE American: IGC) today announced the results of an interim analysis of its ongoing Phase 2 trial investigating IGC-AD1 as a treatment for Agitation in dementia from Alzheimer’s Disease (“AAD”).

Key Points: 
  • IGC Pharma, Inc. (“IGC Pharma”, “IGC”, or the “Company”) (NYSE American: IGC) today announced the results of an interim analysis of its ongoing Phase 2 trial investigating IGC-AD1 as a treatment for Agitation in dementia from Alzheimer’s Disease (“AAD”).
  • The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer’s disease, indicating strong therapeutic potential for IGC-AD1.
  • "We are excited with the positive interim results from the Phase 2 trial of IGC-AD1 for agitation in dementia due to Alzheimer's disease.
  • IGC-AD1’s interim results demonstrate a clinical and statistically significant reduction in agitation compared to placebo, suggesting a strong plausibility to address a substantial unmet medical need.

Lenovo Vehicle Computing and WeRide Forge a Strategic Partnership, using NVIDIA DRIVE Thor Platform to Accelerate Autonomous Driving

Retrieved on: 
Tuesday, March 19, 2024
AD1, Level, Partnership, SAN, WeRide, AI, Thought, Architecture, Multimedia, NVIDIA, Automotive industry, Video game

SAN JOSE, Calif., March 19, 2024 /PRNewswire/ -- Lenovo Vehicle Computing and WeRide recently formed a strategic partnership to create Level 4 autonomous driving solutions for commercial applications.

Key Points: 
  • SAN JOSE, Calif., March 19, 2024 /PRNewswire/ -- Lenovo Vehicle Computing and WeRide recently formed a strategic partnership to create Level 4 autonomous driving solutions for commercial applications.
  • The cutting-edge intelligent-driving solution developed by Lenovo Vehicle Computing and WeRide is based on Lenovo's recently unveiled autonomous driving domain controller, AD1, built on the NVIDIA DRIVE Thor platform featuring the new Blackwell architecture designed for transformer and generative AI workloads.
  • The AD1 will be integrated on the WeRide One, a highly compatible autonomous driving solution platform, for use in a wide range of urban-centered target use cases.
  • As a leader in large-scale general computing, Lenovo Vehicle Computing is pleased to collaborate with WeRide and NVIDIA.

United Arab Emirates Data Center Market Investment Analysis & Growth Opportunities 2024-2029 Featuring Key DC Investors - CtrlS, Equinix, Core42, Khazna, Gulf Data Hub, Moro Hub, and Pacific Controls - ResearchAndMarkets.com

Retrieved on: 
Friday, March 1, 2024
Data Management, Technology, Commercial Building & Real Estate, Construction & Property, Networks, Hardware, Cloud, Xchange, DX1, FLAG, AD1, USD, Investment, DAMAC, DX2, Growth, Global Cloud Xchange, City, FEA, G42, Etisalat by e&, Drug

The "United Arab Emirates Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United Arab Emirates Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report has been added to ResearchAndMarkets.com's offering.
  • Khazna Data Centers is among the top and largest data center operators in the UAE data center market.
  • Some of the key colocation investors in the UAE data center market in 2023 are Gulf Data Hub, Khazna Data Centers, Moro Hub, Equinix, and others.
  • The Gulf Data Hub is also among the major operators in the UAE data center market.

United Arab Emirates Data Center Market Investment Analysis Report 2023-2029: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards

Retrieved on: 
Thursday, February 29, 2024
Cloud, Xchange, DX1, FLAG, AD1, USD, Investment, DAMAC, DX2, Growth, Global Cloud Xchange, City, FEA, G42, Etisalat by e&, Drug

DUBLIN, Feb. 28, 2024 /PRNewswire/ -- The "United Arab Emirates Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 28, 2024 /PRNewswire/ -- The "United Arab Emirates Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report has been added to ResearchAndMarkets.com's offering.
  • The UAE data center market was valued at USD 1.50 Billion in 2023 and is expected to reach a value of $2.65 billion in 2029, growing at a CAGR of 9.95% from 2023-2029
    This report analyses the UAE data center market share.
  • Khazna Data Centers is among the top and largest data center operators in the UAE data center market.
  • Snapshot of existing and upcoming third-party data center facilities in UAE:
    Data Center Colocation Market in UAE:
    The UAE data center market investments are classified into IT, power, cooling, and general construction services with sizing and forecast.

AD1 Global Appoints New Chief Strategy Officer Bryan Hayes

Retrieved on: 
Thursday, June 1, 2023
Vice, Senior, Business, Hyatt, Hayes, Purdue University, White Lodging, Growth, Purdue University Global, AD1, Hyatt House, Management, Hotel

HOLLYWOOD, Fla. , May 31, 2023 /PRNewswire/ -- AD1 Global is pleased to announce the appointment of Bryan Hayes as Chief Strategy Officer.

Key Points: 
  • HOLLYWOOD, Fla. , May 31, 2023 /PRNewswire/ -- AD1 Global is pleased to announce the appointment of Bryan Hayes as Chief Strategy Officer.
  • Prior to Corporex, Bryan served as the Chief Operating Officer of White Lodging, a prominent hospitality company based in Indiana.
  • As Chief Strategy Officer of AD1 Global, Bryan will leverage his extensive industry knowledge and strategic acumen to guide the company's growth and expansion plans.
  • "We are thrilled to welcome Mr. Hayes to the AD1 family as Chief Strategy Officer," said Daniel Berman, CEO.

ASLAN Pharmaceuticals Presents New Data on Eblasakimab in Multiple Posters at the 31st Annual European Academy of Dermatology and Venereology (EADV) Congress

Retrieved on: 
Wednesday, September 7, 2022
NASDAQ, Immunoglobulin E, Itch, Sleep, Serum, Congress, POC, TARC, ASLN, GLOBE, Surround optical-fiber immunoassay, European Academy of Allergy and Clinical Immunology, Atopy, Atopic dermatitis, Biomarker, AD, AD1, Patient, LDH, Vaccine, Pharmaceutical industry, Venereology, Dermatology

Three posters are being presented as e-posters throughout the duration of the congress from September 7 to 10, 2022.

Key Points: 
  • Three posters are being presented as e-posters throughout the duration of the congress from September 7 to 10, 2022.
  • Collectively, the data being presented at EADV gives us great confidence to continue investigating eblaskaimabs role in AD and other indications in the future.
  • Signaling through the Type 2 receptor induces expression of a multitude of marker molecules, correlating with disease severity.
  • The poster shows results of patient samples from the proof-of-concept (PoC) trial of eblasakimab in adults with moderate-to-severe atopic dermatitis.

Slate Asset Management Provides $14.9 Million Loan Secured by Tru by Hilton Hotel in Dania Beach, FL

Retrieved on: 
Wednesday, May 4, 2022
Commercial Building & Real Estate, Construction & Property, Finance, REIT, Professional Services, Building Systems, Destinations, Vacation, Travel, Slate, Tru, Airport, Port Everglades, Hilton, Hilton Hotels & Resorts, Capital Group Companies, Industry, Fortification, AD1, Acquisition, Fort Lauderdale–Hollywood International Airport, Commercial property, Financial services

Slate Asset Management (Slate), a global alternative investment platform targeting real assets, announced today that Slate Real Estate Capital has closed a $14.9 million senior loan facility provided to AD1 Global (AD1) to refinance the Tru by Hilton Hotel (the hotel) located in Dania Beach, Florida.

Key Points: 
  • Slate Asset Management (Slate), a global alternative investment platform targeting real assets, announced today that Slate Real Estate Capital has closed a $14.9 million senior loan facility provided to AD1 Global (AD1) to refinance the Tru by Hilton Hotel (the hotel) located in Dania Beach, Florida.
  • The hotel is also in close proximity to the Port Everglades, one of the top three cruise ports in the world, and Dania Beach, a popular tourist destination.
  • In January, Slate Real Estate Capital closed a $16.5 million bridge loan provided to AD1 to refinance the Wyndham Garden Hotel in Dania Beach, Florida.
  • Slate is an active lender through its real estate credit platform, Slate Real Estate Capital, which provides transitional capital and flexible liquidity to strong sponsors and assets across the commercial real estate industry.

AC Immune ACI-24 Data in Brain Communications Show Abeta Vaccine-Candidate Induces Immunity Against pyroGlu-Abeta, Key Driver of Alzheimer’s Disease

Retrieved on: 
Friday, February 4, 2022
AC, CEO, NO, Patient, Neurotoxicity, Synucleinopathy, NASDAQ, GB, Neurology, AU, Janssen Pharmaceuticals, Plaque, JP, Nerve, Down syndrome, Aggregation, Hoffmann-La Roche, AD1, Vaccination, Partnership, The New England Journal of Medicine, Animal, Janssen, Precision medicine, Veni, vidi, vici, Company, Neurodegeneration, Alzheimer's disease, GLOBE, AD, Data, RU, Mouse, Genentech, N-terminus, Peptide, CH, Eli Lilly and Company, Antibody, DS, Vaccine, Pharmaceutical industry, Amyloid beta, EU

LAUSANNE, Switzerland, Feb. 04, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that preclinical data on the optimized formulation of its wholly-owned amyloid-beta (Abeta) vaccine program, ACI-24, were published in the peer reviewed journal Brain Communications. Based on these and other preclinical data, as well as the results of three clinical trials with ACI-24, AC Immune plans to advance clinical development of the optimized formulation to the next stage for both Alzheimer’s disease (AD) and Down syndrome (DS) related AD in 2022.

Key Points: 
  • Pyroglutamate Abeta (pyroGlu-Abeta) peptides, truncated forms of the Abeta protein, are highly neurotoxic Abeta species, which are observed only in brain amyloid plaques and believed to be key drivers of AD1.
  • Specifically, in the study, conducted in mice and non-human primates, optimized ACI-24 generated a strong immune response against both the full length Abeta (Abeta1-42) and pyroGlu-Abeta.
  • It is designed to prevent Abeta plaque accumulation and enhance plaque clearance by generating antibodies against pathological Abeta, including oligomeric Abeta and pyroGlu-Abeta.
  • SupraAntigen is a registered trademark ofAC Immune SAin the following territories: AU, EU, CH, GB, JP and RU.

Slate Asset Management Provides $16.5 Million Loan Secured by Wyndham Garden Hotel in Dania Beach, FL

Retrieved on: 
Monday, January 24, 2022
Commercial Building & Real Estate, Construction & Property, Finance, REIT, Professional Services, Building Systems, Destinations, Vacation, Travel, Slate, Airport, Port Everglades, Philosophy, Travel, Wyndham Hotels & Resorts, Industry, Heart, AD1, Fort Lauderdale–Hollywood International Airport, Partnership, Fortification, Capital Group Companies, Acquisition, Financial services

Slate Asset Management (Slate or the firm), a global alternative investment platform focused on real estate, announced today that Slate Real Estate Capital I has closed a $16.5 million bridge loan provided to AD1 Global (AD1) to refinance the Wyndham Garden Hotel (Wyndham Garden or the hotel) located in Dania Beach, Florida.

Key Points: 
  • Slate Asset Management (Slate or the firm), a global alternative investment platform focused on real estate, announced today that Slate Real Estate Capital I has closed a $16.5 million bridge loan provided to AD1 Global (AD1) to refinance the Wyndham Garden Hotel (Wyndham Garden or the hotel) located in Dania Beach, Florida.
  • Slate is an active lender through its real estate credit platform, Slate Real Estate Capital, which provides transitional capital and flexible liquidity to strong sponsors and assets across the commercial real estate industry.
  • The Wyndham Garden is a 142-key hotel built in 2019, which sits within the heart of greater Fort Lauderdale, a popular travel destination.
  • Slate Asset Management is a global alternative investment platform focused on real estate.